Photo
 Photo
12years of development
3820customer services
28countries have layouts
15self-developed patents
PRODUCTS
Make products that satisfy customers with dedication
ABOUT US
JZ Biotech was established in 2016,located in Shenzhen National Biomedical Industrial Park.
It is a national high-tech enterprise specializing in the research, development and production of immunerelated reagents.dedicated to the in vitro diagnosis (IVD) industry in the life and health industry, focusing on point-of-care Testing(POCT). JZ's unique point-of-care Testing(POCT) technology and multi index joint detection technology are in the leading position in the world.
VISIONBuilding industry benchmarks
VALUESBased on quality
MISSIONServing the entire society
COMPANY NEWS
Understand our activities and announcements
  • Double -track success, setting the trend! Double -track success, setting the trend! JZ BIOTECH's Animal Professional Otoscope captivated both the IAVC 2025 offline exhibition and online booth. At the highly anticipated IAVC 2025 exhibition, our Animal Professional Otoscope undoubtedly stole the spotlight, drawing numerous veterinarians and industry experts for extended hands-on experiences. A steady stream of professionals gathered at our booth for consultations and exchanges. While the offline buzz remained intense, the online wave surged even higher! Inquiries and orders in the cloud exhibition hall skyrocketed, achieving double success. With exceptional imaging clarity, user-friendly operation design, and unwavering product quality, we earned unanimous recognition and acclaim from both on-site and cloud markets. This triumph is not merely a product victory—it stands as a powerful affirmation of our deep expertise in the animal healthcare field! Moving forward, we will continue to innovate and advance, committed to providing stronger, more robust support for global animal health initiatives.

    2025-0903

  • New Insights on Feline Heart Health New Insights on Feline Heart Health A recent study found that cats with Hypertrophic Cardiomyopathy (HCM)—a serious heart condition—show higher D-dimer levels and lower prothrombin time (PT). This suggests D-dimer could help identify cats at risk for dangerous blood clots caused by their heart disease. Key takeaways: D-dimer elevation may signal clotting risk PT changes reflect altered coagulation Proteomics reveals new protein markers Full study: Jiwaganont P, et al. BMC Vet Res. 2024. DOI: 10.1186/s12917-024-04170-0

    2025-0903

  • The three-day IAVC2025 concluded successfully in Hong Kong on August 14th.The three-day IAVC2025 concluded successfully in Hong Kong on August 14th. The conference has concluded successfully, but our journey continues. The insights and achievements gained at IAVC2025 will continue to inspire JZ BIOTECH to deepen its commitment to animal health—driven by innovation and customer-centricity, dedicated to providing more advanced and reliable diagnostic solutions. We will work with our partners to promote high-quality development in animal health. We look forward to meeting you again—whether at the next industry event or through our daily collaborations—to create a brighter, healthier future for animals together.

    2025-0903

  • JZ Biotech Co.Ltd
  • +86-755-89218110
  • 19926642670(Mr.Wang)
  • market@n-jz.com
  • Room 101,Building B2,NO.13,Baolan Road,Xiuxin Community,KengziStreet,Pingshan District,Shenzhen City,P.R.China,518122
  • Mobile version
  • WeChat
JZ Biotech Co.Ltd 2025 all rights reserved
WeChat Sharing Guide
Open the WeChat app, scan the QR code on the left; then click on the icon in the upper left corner of WeChat to share with friends or Moments.